KYP-2047 is primarily used in research settings to study the role of prolyl oligopeptidase (POP) inhibition in various biological processes. It is particularly valuable in neuroscience research, where it helps investigate the potential therapeutic effects of POP inhibition on neurodegenerative diseases such as Parkinson's and Alzheimer's. By blocking POP activity, KYP-2047 aids in understanding the regulation of neuropeptides and their impact on cognitive and motor functions. Additionally, it is utilized in exploring its anti-inflammatory and neuroprotective properties, offering insights into potential treatments for brain injuries and psychiatric disorders. Its application extends to pharmacological studies aiming to develop novel therapies targeting POP-related pathways.